Company Profile
CEO
Mr. William J. Meury(CEO & Director)
Sector
Healthcare
Industry
Biotechnology
Employees
2.8K
Beta
0.79
Forward P/E
11.3
52W High
$112.29
52W Low
$66.74
Profit Margin
26.7%
Operating Margin
25.6%
Return on Equity
30.8%
Revenue Growth
20.9%
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-vers...
Valuation
Market Cap$20.11B
P/E (TTM)14.22
P/S (TTM)3.95
EV/EBITDA--
Cash Flow
FCF Yield+5.2%
SBC Adj. FCF Yield+3.9%
SBC Impact24.4%
Margins & Growth
Profit Margin23.8%
Operating Margin23.7%
Revenue YoY20.9%
Earnings YoY91.7%
Balance
Cash$3.46B
Debt--
Net Cash--
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--